首页> 美国卫生研究院文献>BMC Biology >Antibiotic resistance: it’s bad but why isn’t it worse?
【2h】

Antibiotic resistance: it’s bad but why isn’t it worse?

机译:抗生素抗性:不好但是为什么不更糟呢?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Antibiotic natural products are ancient and so is resistance. Consequently, environmental bacteria harbor numerous and varied antibiotic resistance elements. Nevertheless, despite long histories of antibiotic production and exposure, environmental bacteria are not resistant to all known antibiotics. This means that there are barriers to the acquisition of a complete resistance armamentarium. The sources, distribution, and movement of resistance mechanisms in different microbes and bacterial populations are mosaic features that act as barriers to slow this movement, thus moderating the emergence of bacterial pan-resistance. This is highly relevant to understanding the emergence of resistance in pathogenic bacteria that can inform better antibiotic management practices and influence new drug discovery.
机译:抗生素天然产物是古老的,抗药性也是古老的。因此,环境细菌具有众多多样的抗生素抗性元素。尽管如此,尽管抗生素生产和接触已有悠久的历史,但环境细菌并非对所有已知的抗生素都有抗药性。这意味着获得完整的抵抗军备库存在障碍。不同微生物和细菌种群中抗药性机制的来源,分布和运动是镶嵌特征,它们是阻碍这种运动减慢速度的障碍,从而减缓了细菌泛抗性的出现。这与了解致病菌耐药性的出现高度相关,这些细菌可以指导更好的抗生素管理实践并影响新药的发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号